Starting Dose of Quetiapine (Seroquel)
For adults with schizophrenia or bipolar mania, start quetiapine at 25 mg twice daily (50 mg total on Day 1), then rapidly titrate upward over 3-4 days to reach 300-400 mg/day by Day 4. 1
Standard Adult Dosing by Indication
Schizophrenia (Adults)
- Day 1: 25 mg twice daily (50 mg/day total)
- Day 2: Increase to 50-75 mg twice daily (100-150 mg/day)
- Day 3: Increase to 100-150 mg twice daily (200-300 mg/day)
- Day 4: Target 150-200 mg twice daily (300-400 mg/day)
- Therapeutic range: 150-750 mg/day
- Maximum: 750 mg/day 1
Bipolar Mania (Adults)
- Day 1: 50 mg twice daily (100 mg/day total)
- Day 2: 100 mg twice daily (200 mg/day)
- Day 3: 150 mg twice daily (300 mg/day)
- Day 4: 200 mg twice daily (400 mg/day)
- Therapeutic range: 400-800 mg/day
- Maximum: 800 mg/day 1
Bipolar Depression (Adults)
- Day 1: 50 mg once daily at bedtime
- Day 2: 100 mg at bedtime
- Day 3: 200 mg at bedtime
- Day 4: 300 mg at bedtime (target dose)
- Maximum: 300 mg/day 1
Adolescent Dosing (13-17 years for Schizophrenia; 10-17 years for Bipolar Mania)
Schizophrenia (Adolescents 13-17 years)
- Day 1: 25 mg twice daily (50 mg/day)
- Day 2: 50 mg twice daily (100 mg/day)
- Day 3: 100 mg twice daily (200 mg/day)
- Day 4: 150 mg twice daily (300 mg/day)
- Day 5: 200 mg twice daily (400 mg/day)
- Therapeutic range: 400-800 mg/day
- Maximum: 800 mg/day 1
Bipolar Mania (Children/Adolescents 10-17 years)
- Same titration schedule as adolescent schizophrenia
- Therapeutic range: 400-600 mg/day
- Maximum: 600 mg/day 1
Special Population Adjustments
Elderly Patients
Start at 50 mg/day (not 25 mg twice daily), then increase by 50 mg/day increments based on tolerability. 1 This slower titration is critical because elderly patients have increased risk of:
- Orthostatic hypotension (particularly problematic with quetiapine) 2
- Falls and cognitive impairment 3
- Mortality (especially when combined with dementia) 4, 3
Hepatic Impairment
Start at 25 mg once daily, then increase by 25-50 mg/day increments to effective dose. 1 Quetiapine undergoes extensive hepatic metabolism, requiring dose reduction in liver disease.
Alzheimer's Disease/Dementia with Behavioral Disturbances
Start at 12.5 mg twice daily (25 mg/day total), with maximum of 200 mg twice daily (400 mg/day). 2 Key considerations:
- More sedating than other atypical antipsychotics
- Beware of transient orthostasis - a critical safety concern in this population 2
- Use only for severe agitation, delusions, hallucinations, or combativeness that hasn't responded to non-pharmacological interventions
Delirium (Cancer Patients)
Start at 25 mg PO once (immediate release), then give every 12 hours if scheduled dosing required. 5 Quetiapine is:
- More sedating than other options
- Less likely to cause extrapyramidal symptoms
- May cause orthostatic hypotension and dizziness
- Reduce dose in elderly and hepatically impaired patients 5
Drug Interaction Adjustments
When co-administered with potent CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir, nefazodone), reduce quetiapine dose to one-sixth of the original dose. 1 When the inhibitor is discontinued, increase quetiapine back to the original dose (6-fold increase).
With paroxetine or fluvoxamine in depression: Initial doses should be substantially reduced due to significant DDIs affecting quetiapine clearance 6:
- Paroxetine reduces clearance by approximately 46%
- Fluvoxamine reduces clearance by approximately 52%
- Combined use reduces clearance by approximately 74%
Clinical Pearls and Pitfalls
Rapid Titration is Safe and Effective
Research demonstrates that reaching 400 mg/day in 2-3 days (rather than the traditional 5 days) is well-tolerated in acutely ill hospitalized patients with schizophrenia 7. However, the FDA-approved label maintains the more conservative 4-5 day schedule 1.
Target Dose for Efficacy
For acute mania, the mean effective dose among responders is approximately 600 mg/day, with most patients responding within the 400-800 mg/day range. 8 This suggests 600 mg/day is an appropriate target dose for mania, not just the minimum of 400 mg/day.
Common Adverse Effects During Titration
- Somnolence (25-39% of patients) - most common side effect 3
- Orthostatic hypotension (6-18%) - particularly dangerous in elderly 2, 3
- Dizziness (15-27%) 3
- Weight gain (11-30%) - monitor from initiation 3
Critical Safety Warnings
- Black box warning: Increased mortality in elderly patients with dementia-related psychosis 1
- Orthostatic hypotension risk: Monitor blood pressure, especially during initial titration and in elderly patients 2, 1
- Metabolic effects: Obtain baseline glucose, lipids, weight, and BMI before starting 9
- In older adults, quetiapine shows increased risk of mortality, dementia, and falls compared to trazodone, and increased dementia risk compared to mirtazapine when used for insomnia 4
Off-Label Use Cautions
While quetiapine is commonly used off-label for insomnia (typically 25-100 mg at bedtime) 10, 4, this practice carries significant risks in older adults, including increased mortality and cognitive decline 4, 3. If prescribing for insomnia in elderly patients, strongly consider trazodone or mirtazapine as safer alternatives. 4